Alzheimer's drug approval gets a mixed reception.
Where this comes from
- Record sourced from PubMed, PMID 36634171.
- Also identified by DOI 10.1126/science.adg6275.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
FDA allows use of antibody despite ongoing debates over its benefits and dangers.
Medical subject headings
- Alzheimer Disease
- Antibodies, Monoclonal, Humanized
- Drug Approval